New Zealand Cannabis Law

New Zealand narrowly voted against adult-use legalization in its 2020 cannabis referendum (46.1% in favor), but maintains a functioning medical cannabis framework established by the Misuse of Drugs Amendment Act 2018. The Medicinal Cannabis Scheme, administered by the Ministry of Health, regulates cultivation, manufacturing, and import/export of medical cannabis products. New Zealand's pharmaceutical-grade standards and regulatory transparency make it an attractive jurisdiction for specialty medical cannabis producers.

New Zealand's geographic proximity to Australia and the existing Australia-New Zealand Closer Economic Relations (CER) trade framework create potential for coordinated trans-Tasman cannabis supply chain development. The New Zealand government has indicated openness to further liberalization, particularly for hemp-based products.

Bob Hoban has advised operators on New Zealand's Medicinal Cannabis Scheme compliance, license application strategy, and the CER's implications for trans-Tasman cannabis trade. Advisory areas include Medsafe licensing requirements, the Ministry of Health's Medicinal Cannabis Scheme, hemp product compliance under New Zealand food law, and investment structuring for New Zealand market entry by international operators.